SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending after Hapag-Lloyd confirmed an agreement to acquire the shipping company for $35 per share, prompting community discussion about potential dividends before the expected 2026 closing. Many are eyeing a potentially higher final price due to the company's perceived undervaluation, geopolitical considerations, and the possibility of a short squeeze.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

401JK is trending as a 'Pure Belief Asset' driven by a passionate community's 'Resist & Retire' movement, challenging traditional financial systems through memes and active building. Its growing presence on platforms like Coinbase and in top crypto subreddits highlights its anti-establishment appeal amidst prevailing market volatility.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Helium is actively discussed following recent regulatory clarity and a new AT&T partnership, with the community closely watching its consolidating tokenomics as rewards shift to HNT, reinforcing its position within the growing DePIN sector.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue is trending due to active arbitrage plays stemming from its proposed acquisition by Kimberly-Clark below the offer price, while widespread community debate surrounds ongoing lawsuits alleging Tylenol's link to autism, with many dismissing these claims as politically driven.

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Celldex Therapeutics Inc.

Celldex Therapeutics is trending following strong clinical data for its lead drug barzolvolimab in chronic urticaria, with the community anticipating it as a potential best-in-class treatment or buyout target despite ongoing discussions about its safety profile and long development timeline.

MasTec, Inc. engages in the provision of infrastructure construction services. It operates through the following segments: Communications, Oil and Gas, Clean Energy and Infrastructure, and Other. The Communications segment performs engineering, construction, maintenance, and customer fulfillment activities related to communications infrastructure, primarily for wireless and wireline/fiber communications, and install-to-the-home customers. The Oil and Gas segment offers services on oil and natural gas pipelines and processing facilities for the energy and utilities industries. The Clean Energy and Infrastructure segment serves energy, utility and other end-markets through the installation and construction of power generation facilities, including from clean energy and renewable sources such as wind, solar and biomass, as well as various types of heavy civil and industrial infrastructure. The Other segment consists of equity investors, other small business units that perform construction, and other services for a variety of international end-markets. The company was founded by Jorge Mas Canosa on July 26, 1968, and is headquartered in Coral Gables, FL.

Mastec Inc.

MasTec is gaining traction from strong recent earnings and an elevated outlook, driven by robust demand in its communications and power delivery segments, particularly benefiting from the AI-driven data center infrastructure boom. The community is actively discussing its momentum as an "old economy" stock thriving on significant infrastructure spending and a record backlog.

Tidal Trust II - YieldMax HOOD Option Income Strategy ETF

YieldMax HOOD Option Income Strategy ETF

YieldMax HOOD Option Income Strategy ETF (HOOY) is a top talking point for its new weekly distribution schedule, as investors weigh its attractive high yield against persistent community concerns about potential capital depreciation, all while keeping an eye on the underlying HOOD's market performance.

Green Plains, Inc. engages in the production of fuel-grade ethanol and corn oil, the provision of grain handling, and storage commodity marketing and distribution services. It operates through the following segments: Ethanol Production and Agribusiness and Energy Services. The Ethanol Production segment produces ethanol, distillers' grain, and corn oil at ethanol plants in Indiana, Iowa, Minnesota, Nebraska, Tennessee, and Texas. The Agribusiness and Energy Services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, renewable corn oil, natural gas and other commodities. The company was founded in June 2004 and is headquartered in Omaha, NE.

Green Plains Inc

Green Plains Inc. is trending amid activist investor Ancora's call for the company to explore a sale, fueling community discussion on its strategic future. This comes as the company highlights significant advancements in carbon capture and securing 45Z clean fuel tax credits, which are seen as pivotal for its low-carbon growth trajectory.

Based Chad

CHAD is trending as Coinbase executives reportedly continue to buy and stake the token, signaling strong insider confidence alongside active community engagement and the upcoming release of a video game. The community is highly bullish, emphasizing its multichain presence, deflationary buybacks, and consistent outperformance among memecoins.

Renaissance Capital Greenwich Funds - Renaissance International IPO ETF

The Renaissance International IPO ETF ($IPOS) is garnering significant attention from retail investors, with sustained chatter across social media platforms discussing its performance and notable option activity. This ETF remains a focal point for those looking to gauge or capitalize on the dynamic landscape of international initial public offerings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder...

Firefly Neuroscience rallied in its strongest session in more than a month on Tuesday after unveiling its new Clear Platform, a proprietary electroencephalogram (EEG) preprocessing technology built with Nvidia’s L40S GPU acceleration.The stock closed up 4.6% at $2.71 on Tuesday and added another 1.5% in after-hours trade.The medtech firm stated that the system achieves substantial processing speed gains of 60–80% while maintaining high signal quality, thereby enabling cleaner brainwave data for biomarker discovery and clinical research.&nbsp;Firefly stated that the platform could unlock new AI-driven insights to advance the diagnosis, treatment, and monitoring of neurological and psychiatric conditions.“Data quality is the foundation of clinical insight,” said Gil Issachar, Firefly’s Chief Technology Officer. “By combining our advanced preprocessing methods with Nvidia GPU acceleration, the Clear Platform represents the achievement of a key milestone along our path of building a foundation model of the human brain.”The launch comes months after&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aiff-stock-soars-after-nvidia-connect-program-nod/ch5au23RuF">Firefly was accepted into the Nvidia Connect Program</a>, which provides participating companies with software development resources and technical training.CEO Greg Lipschitz said the rollout will play a central role in the company’s growth strategy, supporting efforts to discover and advance breakthrough brain biomarkers that can aid pharmaceutical R&amp;D, clinical trials, and patient care.Firefly develops AI-driven brain health tools and already holds FDA clearance for its Brain Network Analytics technology, which supports diagnosis and treatment monitoring for depression, dementia, anxiety, concussions, and ADHD.On Stocktwits, retail sentiment for Firefly was ‘extremely bullish’ amid an 11,700% surge in 24-hour message volume.One user described the stock as “a pound on the table” buy, calling it a potential multibagger in its early stages.<stembedurl>https://stocktwits.com/elgreg_2002/message/626646720</stembedurl>Another user predicted Firefly’s software could become the future of EEG diagnostics, noting that current brainwave readings are often noisy and time-consuming to interpret.&nbsp;With AI-driven clarity, they said, the company could cut delays in diagnosis and “be making a fortune.”<stembedurl>https://stocktwits.com/megamaven/message/626633235</stembedurl><a href="https://stocktwits.com/symbol/AIFF">Firefly Neuroscience’s stock</a> has risen 2.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Firefly Neuroscience’s stock has risen 2.3% so far in 2025. (Photo credit: Getty Images)

Firefly Neuroscience Stock Scores Biggest Gain In Weeks On Nvidia Brain Platform Boost: Retail Says ‘Pound On The Table’ Buy

The surge followed the debut of Firefly’s Clear EEG technology, which promises faster, cleaner brain data for biomarker discovery. 

Equity

This Hidden-Gem Stock Is Skyrocketing on Nvidia News. Should You Buy It Now?

Firefly Neuroscience’s stock has skyrocketed over 200% in five days after joining Nvidia’s Partner Connect Program.

Shares of Firefly Neuroscience Inc. surged more than 30% on Wednesday afternoon, reaching their highest levels in over nine months.&nbsp;The micro-cap medtech firm’s stock was experiencing the largest jump in retail following among health care stocks on Stocktwits, with trading volume nearly 10 times the daily average of 7.29 million shares.The rally followed Firefly’s announcement on Tuesday that it had been accepted into the Nvidia Connect program, which provides participating companies with software development resources and technical training.Firefly plans to leverage these tools to build a human brain foundation model using its FDA-cleared Brain Network Analytics (BNA) technology platform.&nbsp;Developed with artificial intelligence and machine learning, BNA aims to enhance doctors’ insights into brain function and improve diagnostic accuracy for patients with neurological and mental disorders.That announcement sent Firefly shares rocketing 170% higher on Tuesday, marking their best session ever.On Stocktwits, Firefly — currently valued at just $88.6 million — has drawn increasing attention.&nbsp;Its retail following has soared by nearly 70% over the past month, while message volume has exploded by more than 168,000%.&nbsp;A poll on the platform asking whether the stock’s squeeze had real momentum saw 62% of respondents voting “Yes, $20+ soon,” while 28% called it a “pump and dump.”<figure class="image"><img style="aspect-ratio:1290/644;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/AIFF_Stocktwits_Poll_On_Feb_12_0cf377b1b2.png" alt="AIFF Stocktwits Poll On Feb 12.png" width="1290" height="644"><figcaption>AIFF Stocktwits Poll On Feb 12</figcaption></figure>Short interest in Firefly has jumped from 2.6% at the start of the year to 26.7% by the end of January, according to Koyfin data.&nbsp;The company went public via a $45 million reverse merger with IT group WaveDancer last August, and shares have gained nearly 37% since then.For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Stocktwits, Firefly — currently valued at just $88.6 million — has drawn increasing attention. | Image source: Getty Images

Firefly Neuroscience Leads Health Care Retail Follower Surge After Nvidia Connect Program Nod Sends Stock Soaring

The medtech firm plans to leverage these tools to build a human brain foundation model using its FDA-cleared Brain Network Analytics technology platform.

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. It offers Brain Network Analytics (BNA) platform, a software as a medical solution for the diagnostic and treatment methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. The company was founded in 1979 and is headquartered in Kenmore, NY.

Firefly Neuroscience Inc.

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$0.78
Prev Close	$0.7591
Open	$0.751
Dividend Yield	0.00%
50-Day Moving Average	$1.12
Beta	1.55
Avg. Volume	93,606.75
PE Ratio	-0.31

52-Week High	$10.60
52-Week Low	$0.711
Market Capitalization	$11.09M
EPS (Annual)	-$1.60
Price to Book	1.09
Revenue Per Employee	$7,714.29

AIFF
Firefly Neuroscience Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest AIFF News

AIFFFirefly Neuroscience Inc.